Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival
Association Between Elevated Plasma D-dimer in Adult Community-acquired Pneumonia Patients and Severity of Inflammatory Response and Survival
1 other identifier
observational
50
1 country
1
Brief Summary
This observational study aims to investigate the association between elevated plasma D-dimer levels and the inflammatory response, as well as its impact on survival in adult patients with community-acquired pneumonia. the study participants will be subjected to sampling for D-dimer and calculation of CURB-65 score. this aims to find the relation between them
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2025
CompletedFirst Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
September 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFebruary 24, 2026
February 1, 2026
11 months
September 22, 2025
February 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
find the correlation between plasma D-dimer level and the severity of CAP
measuring D-dimer level (\< 500 µg/L consider negative) on admission and correlating this with CAP severity.
in 6 months
Study Arms (1)
only one group which will include patients with CAP to take a blood sample for D-dimer
Interventions
blood sample for D-dimer
Eligibility Criteria
the participant is those patients with CAP WHO will meet the inclusion criteria previously mentioned
You may qualify if:
- age ≥18 years
- diagnosis of CAP based on clinical symptoms, laboratory findings, and radiological evidence.
You may not qualify if:
- Patients with a history of coagulation disorders, cancer, or other chronic diseases, or refusal to participate.
- patients who have any clinical or radiological signs suggesting COVID-19 pneumonia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University hospitals
Cairo, Egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
September 22, 2025
First Posted
September 30, 2025
Study Start
March 23, 2025
Primary Completion
March 1, 2026
Study Completion
April 1, 2026
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
to save patients DATA